As experience with these novel antihyperglycemic drugs increases, future studies with longer follow-up periods should be conducted to corroborate our findings. Patients were followed from cohort ...

A latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...

Objective: Published reports suggest that pioglitazone and rosiglitazone have different effects on lipids in patients with type 2 diabetes. However, these previous studies were either ...

Self-monitoring is considered to be a tool to guide patient and physician action with respect to changes in diet, physical activity, and use of antihyperglycemic medication. Both patient and ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

These compounds demonstrated strong antihyperglycemic activities in animal models, with one compound showing effects comparable to the well-known diabetes medication acarbose[1]. This highlights ...

and the non-Ertu group (n=670), which included patients receiving other oral antihyperglycemic drugs (OADs) except ertugliflozin. Patients attended a baseline visit one month before the first day of ...

These findings support the current clinical practice of not recommending one drug over the other for the treatment ... dapagliflozin in adults with type 2 diabetes who were receiving antihyperglycemic ...

Therefore, in the early stages of diabetes, curcumin can be used as a potential complementary treatment option in combination with antihyperglycemic drugs for more effective treatment of diabetic ...

It’s important to remember that many of these medications only work when you take them along with lifestyle measures, such as a balanced, nutritious diet. If you have high triglyceride levels ...

Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the quality of medicine. By Alexandra Stevenson and Zixu Wang Reporting from ...